These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1055310)

  • 1. LATS protector, the human thyroid stimulator.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathogenesis of thyrotoxicosis the discovery of LATS.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulation of the human thyroid by infusions of plasma containing LATS protector.
    Adams DD; Fastier FN; Howie JB; Kennedy TH; Kilpatrick JA; Stewart RD
    J Clin Endocrinol Metab; 1974 Nov; 39(5):826-32. PubMed ID: 4425101
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in LATS and other thyoid autoantibody levels with therapy.
    Kilpatrick JA
    N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence to suggest that LATS protector stimulates the human thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1971 Jul; 33(1):47-51. PubMed ID: 5558041
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.
    Beall GN; Solomon DH
    J Clin Invest; 1966 Apr; 45(4):552-61. PubMed ID: 5937026
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 9. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
    Knight A; Adams DD
    Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
    Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
    J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
    Adams DD; Kennedy TH; Stewart RD
    Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [LATS and thyroid antibody level in the blood in Basedow's disease].
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Orv Hetil; 1968 Aug; 109(33):1799-804. PubMed ID: 5714825
    [No Abstract]   [Full Text] [Related]  

  • 13. The value of IgG separation for the detection of LATS in human serum.
    Bonnyns M; Vanhaelst L
    Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-acting thyroid stimulator.
    Munro DS
    Sci Basis Med Annu Rev; 1970; ():21-30. PubMed ID: 4920180
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
    Lepp A; Oliner L
    Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
    [No Abstract]   [Full Text] [Related]  

  • 16. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
    [No Abstract]   [Full Text] [Related]  

  • 17. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
    [No Abstract]   [Full Text] [Related]  

  • 18. The interaction between LATS and thyroid tissue in vitro.
    Smith BR; Munro DS
    Clin Sci; 1969 Oct; 37(2):566. PubMed ID: 5359011
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)].
    Mertz DP; Stelzer M
    Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881
    [No Abstract]   [Full Text] [Related]  

  • 20. What is the antibody specificity of LATS?
    Fagraeus A; Jonsson J; el-Kabir DJ
    J Clin Endocrinol Metab; 1970 Oct; 31(4):445-7. PubMed ID: 4916544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.